Citigroup »

Spruce Biosciences shares owned by Citigroup

Quarter-by-quarter ownership of Spruce Biosciences (SPRB) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Spruce Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Spruce Biosciences held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spruce Biosciences by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $61k 939 65.35

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Spruce Biosciences

Ikarian Capital
Millennium Management
Citadel Advisors
Wellington Management Company
ADAR1 Capital Management
Alyeska Investment Group
Boothbay Fund Management
Balyasny Asset Management
Carlyle
Quinn Opportunity Partners
Caligan Partners
Stonepine Capital Management
Vanguard Group
BlackRock
Geode Capital Management

View all funds holding Spruce Biosciences